Hani Sbitany, MD
Plastic Surgery · San Francisco, CANPI 1588779870
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $349,172 of the $510,113 with a category attached, or 68.4%. AbbVie accounts for 96.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $177,865 and has fallen 73.0% since, to $48,108 in 2025. Among plastic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 441 payments — averaging $1156.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$492K
- Osiris Therapeutics Inc.$6K
- Smith+Nephew$4K
- Convatec Inc.$4K
- Davol Inc.$2K
- RTI Surgical, Inc$2K
- plus $1K from 6 others
What the payments were for
- Consulting fees$125,47925%
- Speaking & faculty fees$349,17268%
- Travel & lodging$23,4525%
- Food & beverage$12,0102%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 390 | $491,964 |
| Osiris Therapeutics Inc. | 14 | $6,448 |
| Smith+Nephew | 6 | $3,779 |
| Convatec Inc. | 3 | $3,708 |
| Davol Inc. | 14 | $1,561 |
| RTI Surgical, Inc | 1 | $1,500 |
| C. R. Bard, Inc. & Subsidiaries | 4 | $446 |
| Medline Industries LP | 5 | $287 |
| Kerecis Limited | 1 | $181 |
| Sientra, Inc. | 1 | $168 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $58 |
| KCI USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$274,193
- NATRELLE$140,033
- ALLODERM$93,964
- REVOLVE$59,130
- STRATTICE$27,772
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$22,577
- Stravix$10,042
- Grafix$10,042
- GrafixPL$8,665
- ARTIA RECONSTRUCTIVE TISSUE MATRIX$4,200
- AQUACEL AG$3,575
- CORTIVA ALLOGRAFT DERMIS$1,500
- Grafix PL PRIME$1,377
- PHASIX$779
- AVYCAZ$579
- Kerecis Omega3 SurgiClose$543
- TEFLARO$523
- DALVANCE$351
- Hyalomatrix Wound Device$257
- Kerecis Omega3 GraftGuide$181
How this compares
$510,113 in reported general payments places this provider in the 95th percentile of 780 plastic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 25 | $86 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $70 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in San Francisco
- Anne PeledSan Francisco$570K
- Ziv PeledSan Francisco$169K
- Jonathan KaplanSan Francisco$113K
- Dino ElyassniaSan Francisco$108K
- Khashayar MohebaliSan Francisco$75K
- Walter LinSan Francisco$68K
- Rahm NazeraliPalo Alto$1.5M
- Vipul DevBakersfield$1.1M
- Arash MomeniPalo Alto$836K
- Salvatore PacellaSan Diego$517K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.